| Literature DB >> 19345438 |
Maurizio Delvecchio1, Clara Zecchino, Maria Felicia Faienza, Angelo Acquafredda, Fabrizio Barbetti, Luciano Cavallo.
Abstract
A girl with celiac disease and KCNJ11 mutation was transferred to glibenclamide when 19.8 years old. When her compliance to the gluten free diet worsened, her metabolic control deteriorated. Since glibenclamide is absorbed in the intestine, its absorption seems to be impaired by chronic malabsorption, increasing the risk of hyperglycaemia.Entities:
Mesh：
Substances：
Year: 2009 PMID： 19345438 DOI： 10.1016/j.diabres.2009.02.024
Source DB: PubMed Journal: Diabetes Res Clin Pract ISSN： 0168-8227 Impact factor: 5.602